149 related articles for article (PubMed ID: 15879057)
1. Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity.
Proulx K; Cota D; Castañeda TR; Tschöp MH; D'Alessio DA; Tso P; Woods SC; Seeley RJ
Am J Physiol Regul Integr Comp Physiol; 2005 Sep; 289(3):R729-37. PubMed ID: 15879057
[TBL] [Abstract][Full Text] [Related]
2. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.
Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F
Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181
[TBL] [Abstract][Full Text] [Related]
3. Brain molecules and appetite: the case of oleoylethanolamide.
Sarro-Ramírez A; Sánchez-López D; Tejeda-Padrón A; Frías C; Zaldívar-Rae J; Murillo-Rodríguez E
Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):88-91. PubMed ID: 23464987
[TBL] [Abstract][Full Text] [Related]
4. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.
Gaetani S; Oveisi F; Piomelli D
Neuropsychopharmacology; 2003 Jul; 28(7):1311-6. PubMed ID: 12700681
[TBL] [Abstract][Full Text] [Related]
5. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
6. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
Cani PD; Montoya ML; Neyrinck AM; Delzenne NM; Lambert DM
Br J Nutr; 2004 Nov; 92(5):757-61. PubMed ID: 15533263
[TBL] [Abstract][Full Text] [Related]
7. The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice.
Caillon A; Duszka K; Wahli W; Rohner-Jeanrenaud F; Altirriba J
Metabolism; 2018 Oct; 87():13-17. PubMed ID: 29936173
[TBL] [Abstract][Full Text] [Related]
8. Role of oleoylethanolamide as a feeding regulator in goldfish.
Tinoco AB; Armirotti A; Isorna E; Delgado MJ; Piomelli D; de Pedro N
J Exp Biol; 2014 Aug; 217(Pt 15):2761-9. PubMed ID: 24855680
[TBL] [Abstract][Full Text] [Related]
9. Oleoylethanolamide-induced anorexia in rats is associated with locomotor impairment.
Fedele S; Arnold M; Krieger JP; Wolfstädter B; Meyer U; Langhans W; Mansouri A
Physiol Rep; 2018 Feb; 6(3):. PubMed ID: 29388342
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
[TBL] [Abstract][Full Text] [Related]
11. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats.
Tang-Christensen M; Vrang N; Ortmann S; Bidlingmaier M; Horvath TL; Tschöp M
Endocrinology; 2004 Oct; 145(10):4645-52. PubMed ID: 15231700
[TBL] [Abstract][Full Text] [Related]
12. Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake.
Serrano A; Pavón FJ; Tovar S; Casanueva F; Señarís R; Diéguez C; de Fonseca FR
Neuropharmacology; 2011 Mar; 60(4):593-601. PubMed ID: 21172362
[TBL] [Abstract][Full Text] [Related]
13. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion.
Clegg DJ; Wortman MD; Benoit SC; McOsker CC; Seeley RJ
Diabetes; 2002 Nov; 51(11):3196-201. PubMed ID: 12401710
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction.
Yang Y; Chen M; Georgeson KE; Harmon CM
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R235-41. PubMed ID: 16902188
[TBL] [Abstract][Full Text] [Related]
15. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
[TBL] [Abstract][Full Text] [Related]
16. The satiety factor oleoylethanolamide impacts hepatic lipid and glucose metabolism in goldfish.
Gómez-Boronat M; Velasco C; Isorna E; De Pedro N; Delgado MJ; Soengas JL
J Comp Physiol B; 2016 Dec; 186(8):1009-1021. PubMed ID: 27277972
[TBL] [Abstract][Full Text] [Related]
17. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
Sihag J; Jones PJH
Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
[TBL] [Abstract][Full Text] [Related]
18. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.
McMahon LR; Wellman PJ
Am J Physiol; 1998 Jan; 274(1):R23-9. PubMed ID: 9458894
[TBL] [Abstract][Full Text] [Related]
19. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
[TBL] [Abstract][Full Text] [Related]
20. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats.
Fu J; Kim J; Oveisi F; Astarita G; Piomelli D
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R45-50. PubMed ID: 18434444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
